NASDAQ:RCEL
AVITA Medical, Inc. Stock News
$8.10
-0.120 (-1.46%)
At Close: May 24, 2024
AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference
04:01pm, Monday, 13'th Sep 2021
VALENCIA, Calif., and MELBOURNE, Australia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a te
AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference
04:01pm, Tuesday, 31'st Aug 2021
VALENCIA, Calif., and MELBOURNE, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tec
AVITA Medical, Inc.'s (RCEL) CEO Mike Perry on Q4 2021 Results - Earnings Call Transcript
11:18pm, Thursday, 26'th Aug 2021
AVITA Medical, Inc.'s (RCEL) CEO Mike Perry on Q4 2021 Results - Earnings Call Transcript
AVITA Medical Announces Inclusion in the Russell 3000 Index
04:23pm, Tuesday, 29'th Jun 2021
VALENCIA, Calif. and MELBOURNE, Australia, June 29, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
RCEL Stock Price Increases Over 19% Pre-Market: Why It Happened
05:54am, Wednesday, 16'th Jun 2021
The stock price of AVITA Medical Inc (NASDAQ: RCEL) increased by over 19% pre-market. This is why it happened.
AVITA Medical Announces Preliminary Fourth Quarter 2021 Financial Results
06:08pm, Tuesday, 15'th Jun 2021
VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
AVITA Medical Gains FDA Expanded Labels In 'Better Mousetrap' Burn Treatment
03:11pm, Friday, 11'th Jun 2021
The RECELL system gained FDA approval for pediatric and large surface area burns.
AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors
04:01pm, Tuesday, 01'st Jun 2021
VALENCIA, Calif. and MELBOURNE, Australia, June 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and
AVITA: Recell's Growing Upside
09:48am, Wednesday, 19'th May 2021
Avita shareholders' indecisive earnings reaction provided an excellent buying opportunity. The company's pivotal trial delays are disappointing.
AVITA Medical's (RCEL) CEO Mike Perry on Q3 2021 Results - Earnings Call Transcript
09:40pm, Thursday, 13'th May 2021
AVITA Medical's (RCEL) CEO Mike Perry on Q3 2021 Results - Earnings Call Transcript
All You Need to Know About AVITA Medical, Inc. (RCEL) Rating Upgrade to Buy
12:56pm, Wednesday, 14'th Apr 2021
AVITA Medical, Inc. (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
15 RECELL® System Abstracts Accepted for Presentation at 53ʳᵈ Annual American Burn Association Meeting
04:01pm, Tuesday, 30'th Mar 2021
Record Number of Accepted Abstracts Highlight Benefits of RECELL System and Reinforce Rapid Adoption by Surgeons to Advance Burn Care Record Number of Accepted Abstracts Highlight Benefits of RECELL S
Avita Medical, Inc. Announces Closing of Offering of 3,214,250 Shares of Common Stock
06:33pm, Monday, 01'st Mar 2021
VALENCIA, Calif. and MELBOURNE, Australia, March 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and
AVITA Medical, Inc. Announces Pricing of Its Public Offering of Common Stock
12:30am, Thursday, 25'th Feb 2021
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and
AVITA Medical, Inc. Announces Proposed Public Offering of Common Stock
04:01pm, Wednesday, 24'th Feb 2021
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and
